FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Down 49.2% in March

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 960,200 shares, a drop of 49.2% from the February 28th total of 1,890,000 shares. Based on an average daily volume of 7,110,000 shares, the short-interest ratio is currently 0.1 days. Currently, 3.3% of the shares of the stock are short sold.

Hedge Funds Weigh In On FOXO Technologies

An institutional investor recently bought a new position in FOXO Technologies stock. Jane Street Group LLC bought a new stake in FOXO Technologies Inc. (NYSEAMERICAN:FOXO) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned about 0.67% of FOXO Technologies as of its most recent filing with the Securities and Exchange Commission. 44.89% of the stock is currently owned by institutional investors and hedge funds.

FOXO Technologies Stock Down 14.7 %

Shares of NYSEAMERICAN FOXO traded down $0.02 during trading on Friday, hitting $0.12. 1,685,482 shares of the company were exchanged, compared to its average volume of 14,679,984. The company’s fifty day moving average is $0.27. FOXO Technologies has a 12-month low of $0.12 and a 12-month high of $1.30.

About FOXO Technologies

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.